Press release
Oligonucleotide Therapy Market Report Latest Trends and Future Opportunities Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Oligonucleotide Therapy Market is valued at US$ 5.21 Bn in 2023, and it is expected to reach US$ 19.92 Bn by 2031, with a CAGR of 18.6% during the forecast period of 2024-2031.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2566
Oligonucleotides refer to the short-chain RNA or DNA that are generally manufactured by automated synthesizers. The oligonucleotide is purified using anion exchange chromatography, followed by desalting and freezing. The rising incidence of contagious illnesses such as chickenpox, diphtheria, and the common cold is anticipated to propel the expansion of the oligonucleotides market during the projected timeframe. In addition, the development of more stable and prolonged half-life molecules due to the advancement of technologies and the upgradation of chemically synthesized oligonucleotides which is anticipated to boost the growth of the oligonucleotides market at a significant rate over the forecast period. Furthermore, an increasing number of mergers, acquisitions, and product launches among the manufacturers and market players to provide medical care to patients are expected to result in the expansion of the oligonucleotide therapy market.
List of Prominent Players in the Oligonucleotide Therapy Market:
• BPCI Biotech Holding
• SomaGenics Inc
• Hepion Pharmaceuticals
• Alnylam Pharmaceuticals
• Regulus Therapeutics Inc
• Ionis Pharmaceuticals
• Gilead Sciences, Inc
• Santaris
• InteRNA Technologies B.V.
• Mirage
• Biogen
• Merck KgaA
• Pfizer Inc.
Market Dynamics:
Drivers-
Advancements in biotechnology and the pharmaceutical industry are driving the increasing use of synthesized oligos in therapeutic applications. Rising government investments in synthetic biology and genome projects are fueling research and development efforts in oligonucleotide therapeutics, leading to innovative treatments and technologies. Moreover, the growing focus on personalized medicine is shaping the oligonucleotide therapeutics market by tailoring treatments to individual patients based on genetic profiles and specific medical needs. These key drivers are propelling the market towards precision medicine, improved patient outcomes, and the development of targeted therapies for various diseases.
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2566
Challenges:
The inability to detect minor antibodies could hinder market growth by impacting the efficacy and safety of oligonucleotide therapies. This limitation may lead to uncertainties in treatment outcomes and patient responses. Additionally, stringent regulations pose challenges by increasing the complexity and cost of development, approval, and commercialization processes for oligonucleotide therapeutics. Overcoming these obstacles will require advancements in detection technologies, robust clinical data, and strategic compliance measures to navigate regulatory requirements and drive market success. Another challenge is the high cost and complexities of Oligonucleotide Therapy, which is hindering market growth.
Regional Trends:
The North American oligonucleotide Therapy Market is expected to register a maximum market revenue share and it is projected to grow at a high CAGR in the near future. Anticipated revenue growth is expected to be driven by the expansion of oligonucleotide therapies targeting disorders such as cancer and neurological conditions. Besides, Europe had a remarkable share in the market due to increasing demand for custom oligonucleotides in research, diagnostics, and therapeutics. Factors like advancements in synthetic biology, rising applications in precision medicine, and expanding biotechnology and pharmaceutical industries contribute to its expansion.
Recent Developments:
• In May 2023, Chinook Therapeutics and Ionis Pharmaceuticals have partnered to jointly research, develop, and market an antisense oligonucleotide therapeutic aimed at treating a rare and severe chronic kidney disease.
• In March 2023, AusperBio has reported the successful administration of the first dose of AHB-137, an antisense oligonucleotide therapeutic candidate, to a human subject for the treatment of chronic Hepatitis B.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2566
Segmentation of Oligonucleotide Therapy Market-
By Type-
• Antisense
• Ribozymes
• Aptamers
• Mirna
• CpG/Immunostimulatory
• RNAi
By Application-
• Infectious Diseases
• Oncology
• Neurodegenerative Disorders
• Cardiovascular Diseases
• Kidney Diseases
• Others
By End-User-
• Hospitals
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/oligonucleotide-therapy-market/2566
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
According to the latest research by InsightAce Analytic, the Global Oligonucleotide Therapy Market is valued at US$ 5.21 Bn in 2023, and it is expected to reach US$ 19.92 Bn by 2031, with a CAGR of 18.6% during the forecast period of 2024-2031.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2566
Oligonucleotides refer to the short-chain RNA or DNA that are generally manufactured by automated synthesizers. The oligonucleotide is purified using anion exchange chromatography, followed by desalting and freezing. The rising incidence of contagious illnesses such as chickenpox, diphtheria, and the common cold is anticipated to propel the expansion of the oligonucleotides market during the projected timeframe. In addition, the development of more stable and prolonged half-life molecules due to the advancement of technologies and the upgradation of chemically synthesized oligonucleotides which is anticipated to boost the growth of the oligonucleotides market at a significant rate over the forecast period. Furthermore, an increasing number of mergers, acquisitions, and product launches among the manufacturers and market players to provide medical care to patients are expected to result in the expansion of the oligonucleotide therapy market.
List of Prominent Players in the Oligonucleotide Therapy Market:
• BPCI Biotech Holding
• SomaGenics Inc
• Hepion Pharmaceuticals
• Alnylam Pharmaceuticals
• Regulus Therapeutics Inc
• Ionis Pharmaceuticals
• Gilead Sciences, Inc
• Santaris
• InteRNA Technologies B.V.
• Mirage
• Biogen
• Merck KgaA
• Pfizer Inc.
Market Dynamics:
Drivers-
Advancements in biotechnology and the pharmaceutical industry are driving the increasing use of synthesized oligos in therapeutic applications. Rising government investments in synthetic biology and genome projects are fueling research and development efforts in oligonucleotide therapeutics, leading to innovative treatments and technologies. Moreover, the growing focus on personalized medicine is shaping the oligonucleotide therapeutics market by tailoring treatments to individual patients based on genetic profiles and specific medical needs. These key drivers are propelling the market towards precision medicine, improved patient outcomes, and the development of targeted therapies for various diseases.
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2566
Challenges:
The inability to detect minor antibodies could hinder market growth by impacting the efficacy and safety of oligonucleotide therapies. This limitation may lead to uncertainties in treatment outcomes and patient responses. Additionally, stringent regulations pose challenges by increasing the complexity and cost of development, approval, and commercialization processes for oligonucleotide therapeutics. Overcoming these obstacles will require advancements in detection technologies, robust clinical data, and strategic compliance measures to navigate regulatory requirements and drive market success. Another challenge is the high cost and complexities of Oligonucleotide Therapy, which is hindering market growth.
Regional Trends:
The North American oligonucleotide Therapy Market is expected to register a maximum market revenue share and it is projected to grow at a high CAGR in the near future. Anticipated revenue growth is expected to be driven by the expansion of oligonucleotide therapies targeting disorders such as cancer and neurological conditions. Besides, Europe had a remarkable share in the market due to increasing demand for custom oligonucleotides in research, diagnostics, and therapeutics. Factors like advancements in synthetic biology, rising applications in precision medicine, and expanding biotechnology and pharmaceutical industries contribute to its expansion.
Recent Developments:
• In May 2023, Chinook Therapeutics and Ionis Pharmaceuticals have partnered to jointly research, develop, and market an antisense oligonucleotide therapeutic aimed at treating a rare and severe chronic kidney disease.
• In March 2023, AusperBio has reported the successful administration of the first dose of AHB-137, an antisense oligonucleotide therapeutic candidate, to a human subject for the treatment of chronic Hepatitis B.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2566
Segmentation of Oligonucleotide Therapy Market-
By Type-
• Antisense
• Ribozymes
• Aptamers
• Mirna
• CpG/Immunostimulatory
• RNAi
By Application-
• Infectious Diseases
• Oncology
• Neurodegenerative Disorders
• Cardiovascular Diseases
• Kidney Diseases
• Others
By End-User-
• Hospitals
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/oligonucleotide-therapy-market/2566
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
